2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 40.511 | 46.258 | 44.129 | 46.733 | 69.274 | 78.405 | 85.651 | 89.820 | 92.468 | 111.711 |
Total Income - EUR | 40.511 | 46.272 | 44.129 | 46.733 | 69.275 | 78.405 | 87.718 | 101.227 | 92.468 | 111.711 |
Total Expenses - EUR | 31.994 | 37.359 | 37.901 | 37.914 | 47.359 | 65.982 | 73.197 | 92.045 | 81.247 | 85.077 |
Gross Profit/Loss - EUR | 8.517 | 8.913 | 6.228 | 8.819 | 21.916 | 12.423 | 14.521 | 9.183 | 11.221 | 26.634 |
Net Profit/Loss - EUR | 7.301 | 7.525 | 5.787 | 8.049 | 21.223 | 11.639 | 13.665 | 8.284 | 10.295 | 25.517 |
Employees | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Vicamed Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 12.138 | 9.973 | 7.687 | 5.630 | 3.203 | 3.281 | 15.533 | 101.758 | 99.176 | 97.029 |
Current Assets | 12.040 | 23.640 | 27.563 | 34.990 | 6.350 | 16.209 | 36.008 | 9.440 | 20.225 | 12.841 |
Inventories | 0 | 191 | 863 | 1.121 | 13 | 860 | 844 | 0 | 828 | 825 |
Receivables | 3.518 | 4.268 | 3.588 | 5.319 | 6.171 | 13.550 | 31.752 | 7.696 | 7.816 | 10.819 |
Cash | 8.522 | 19.181 | 23.112 | 28.550 | 167 | 1.798 | 3.411 | 1.745 | 11.581 | 1.197 |
Shareholders Funds | 13.709 | 21.348 | 26.917 | 34.511 | 43 | 11.685 | 72 | 8.355 | 18.882 | 44.341 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 46 | 45 | 44 | 45 | 44 |
Debts | 10.470 | 12.264 | 8.332 | 6.108 | 9.511 | 7.805 | 51.469 | 102.844 | 100.519 | 65.530 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Vicamed Srl